cellular therapy

cellular therapy

Fringe medicine
(1) Live cell therapy.
(2) Cell therapy.
 
Mainstream medicine
Stem cell therapy.
References in periodicals archive ?
Terumo BCT announced today that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.
It is anticipated that CMF will have the capacity to supply sufficient quantities of Cellenkos' lead cellular therapy candidate, CK0801, for all company-sponsored clinical trials.
presents readers with a collection of contributions that discuss the current status of cellular therapy for a range of neurological disorders and injuries, including traumatic brain injury, ischemic and hemorrhagic stroke, and spinal cord injury.
M2 EQUITYBITES-June 24, 2015-Benitec Biopharma launches new exploratory cellular therapy programme
Since its inception, Cardio3 BioSciences has demonstrated its competency in cellular therapy, from R&D to manufacturing, to regulatory clinical trials; Cardio3 BioSciences is now engaged in C-Cure's Phase III regulatory pivotal trials process in Europe, U.
The AABB collects feedback from its members, and, in this case, feedback was collected from members with cellular therapy expertise, namely those actively involved in the development, planning, and execution of clinical trials.
This patent has broad-reaching effects, covering research, cellular therapy development and stem cell banking.
based DSM, a developer of materials science and regenerative medicine, has introduced a new service area: cellular therapy development.
DSM offers a complete package of design, development and manufacturing services to create cellular therapy products that, according to company officials, are "clinically valuable and commercially viable.
The company believes that this technology, to induce differentiation without introducing a virus to the cell, provides the company an opportunity to create a series of cellular therapy applications to treat chronic disease and traumatic injury, while at the same time overcoming certain genetic hurdles associated with generic cellular therapies.
com)-- This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences.
This volume follows others in the series on stem cells generally, stem cell plasticity, and neural stem cells and cellular therapy.

Full browser ?